Herfarth H, Klingebiel L, Juhr N C, Grossklaus R
Abt. Gastroenterologie, Universitätsklinikum Essen.
Z Ernahrungswiss. 1994 Sep;33(3):185-94. doi: 10.1007/BF01610784.
The impact of dose-dependent caloric salvage by microbial fermentation processes in the lower gut and the extent of renal excretion for the overall energetic availability of the alternative bulk sweetener Palatinit were investigated in rats. To evaluate the extent of dose-dependent fermentation a conventional and a germ-free rat model were used and fecal excretions of Palatinit after intragastric application were compared. Because of the lack of bacterial colonization in the gastrointestinal tract in germ-free rat the difference in fecal excretion of Palatinit between germ-free and conventional rat is mainly due to bacterial fermentation. To determine the amount of renal excretion of Palatinit the urine was collected. The experiments were conducted using different amounts of Palatinit (300 and 1,200 mg/kg body weight = mg/kg b.w.). Fecal excretions of Palatinit and its monomers (sorbitol and mannitol) were measured by high-performance liquid chromatography (HPLC) and for the determination of renal excretions a gas chromatography system was used. After the application of 300 mg/kg b.w. Palatinit only the breakdown product sorbitol could be recovered in the feces of germ-free rats (29% of the applied dose). No intact Palatinit could be found. In contrast, neither Palatinit nor the breakdown products sorbitol or mannitol could be detected in the feces of conventional rats after application of the same dose. After the application of the higher dose only small amounts of intact Palatinit were found in the feces of germ-free rats (average 12%). There was no intact measurable Palatinit in the feces of conventional rats. The fecal excretions of sorbitol and mannitol in the feces of the germ-free rats were 55% and 39%; in conventional rats only 21% sorbitol was excreted. Only traces of Palatinit, sorbitol or mannitol were found in the urine of conventional and germ-free rats after application of the low as well as the high dose. In conclusion, this study clearly shows the dose dependency of fermentation and therefore the dose dependency of the energetic (i.e., caloric) availability of this disaccharide sugar alcohol. In the calculation of the energy value of Palatinit the renal excretion of Palatinit and its monomers can be neglected.
在大鼠中研究了下消化道微生物发酵过程中剂量依赖性热量 salvage 的影响以及肾排泄对替代大体积甜味剂 Palatinit 整体能量可用性的程度。为了评估剂量依赖性发酵的程度,使用了常规大鼠模型和无菌大鼠模型,并比较了胃内给药后 Palatinit 的粪便排泄情况。由于无菌大鼠胃肠道中缺乏细菌定植,无菌大鼠和常规大鼠之间 Palatinit 粪便排泄的差异主要归因于细菌发酵。为了确定 Palatinit 的肾排泄量,收集了尿液。实验使用了不同量的 Palatinit(300 和 1200 毫克/千克体重 = 毫克/千克体重)进行。通过高效液相色谱法(HPLC)测量 Palatinit 及其单体(山梨醇和甘露醇)的粪便排泄量,并且使用气相色谱系统测定肾排泄量。在给予 300 毫克/千克体重的 Palatinit 后,仅在无菌大鼠的粪便中可回收分解产物山梨醇(占给药剂量的 29%)。未发现完整的 Palatinit。相比之下,在给予相同剂量后,常规大鼠的粪便中未检测到 Palatinit 及其分解产物山梨醇或甘露醇。给予较高剂量后,仅在无菌大鼠的粪便中发现少量完整的 Palatinit(平均 12%)。常规大鼠的粪便中没有可测量的完整 Palatinit。无菌大鼠粪便中山梨醇和甘露醇的粪便排泄量分别为 55%和 39%;在常规大鼠中,仅排泄了 21%的山梨醇。在给予低剂量和高剂量后,常规大鼠和无菌大鼠的尿液中仅发现痕量的 Palatinit、山梨醇或甘露醇。总之,本研究清楚地表明了发酵的剂量依赖性,因此也表明了这种二糖糖醇的能量(即热量)可用性的剂量依赖性。在计算 Palatinit 的能量值时,可以忽略 Palatinit 及其单体的肾排泄。